A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.
Epistemonikos ID: e7bf78c4d48d80782d0602409d7351fc40e38c15
First added on: Oct 02, 2023